Earnings results from the second quarter show that headwinds from MA utilization and Medicaid disenrollment are continuing to put a drag on payer profits. UHG seems to miraculously be above the fray financially, but faces increasing scrutiny from policymakers and the public. Here’s our roundup of recent payvider news:
Strategist | strategy-catalyst